ImmuCell Corporation Construction and Development Costs (Deprecated 2018-01-31)
ImmuCell Corporation (ICCC) reported Construction and Development Costs (Deprecated 2018-01-31) of $4.52 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConstructionAndDevelopmentCosts · last filed 2018-05-14
- ImmuCell Corporation construction and development costs (deprecated 2018-01-31) for the quarter ending 2017-09-30 was -$1.98M, a 109.41% decline year-over-year.
- ImmuCell Corporation construction and development costs (deprecated 2018-01-31) for the quarter ending 2017-06-30 was -$4.75M.
- ImmuCell Corporation construction and development costs (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $11.24M.
- ImmuCell Corporation construction and development costs (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $21.00M.
- ImmuCell Corporation construction and development costs (deprecated 2018-01-31) for fiscal 2016 was $12.32M.
| Period end | Construction and Development Costs (Deprecated 2018-01-31) 3 month | Construction and Development Costs (Deprecated 2018-01-31) 3 month as first filed | Construction and Development Costs (Deprecated 2018-01-31) 6 month | Construction and Development Costs (Deprecated 2018-01-31) 9 month | Construction and Development Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$6.73M derived: sum of 2 quarters · filed 2017-11-13 | $4.52M 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | -$4.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $6.49M 10-Q · filed 2017-08-14 | |||
| 2017-03-31 | $11.24M 10-Q · filed 2017-05-11 | ||||
| 2016-12-31 | $12.32M 10-K · filed 2017-03-30 | ||||
| 2016-09-30 | $21.00M 10-Q · filed 2018-05-14 | $5.00M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |